Annual Current Assets
$483.06 M
+$59.24 M+13.98%
December 31, 2023
Summary
- As of February 7, 2025, FOLD annual total current assets is $483.06 million, with the most recent change of +$59.24 million (+13.98%) on December 31, 2023.
- During the last 3 years, FOLD annual current assets has fallen by -$96.41 million (-16.64%).
- FOLD annual current assets is now -19.06% below its all-time high of $596.83 million, reached on December 31, 2021.
Performance
FOLD Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$498.47 M
+$36.77 M+7.96%
September 30, 2024
Summary
- As of February 7, 2025, FOLD quarterly total current assets is $498.47 million, with the most recent change of +$36.77 million (+7.96%) on September 30, 2024.
- Over the past year, FOLD quarterly current assets has increased by +$35.22 million (+7.60%).
- FOLD quarterly current assets is now -23.38% below its all-time high of $650.54 million, reached on September 30, 2021.
Performance
FOLD Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
FOLD Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +14.0% | +7.6% |
3 y3 years | -16.6% | +7.6% |
5 y5 years | -12.3% | +7.6% |
FOLD Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -19.1% | +14.0% | -16.5% | +24.7% |
5 y | 5-year | -19.1% | +14.0% | -23.4% | +29.9% |
alltime | all time | -19.1% | +1843.2% | -23.4% | +1905.2% |
Amicus Therapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $498.47 M(+8.0%) |
Jun 2024 | - | $461.70 M(+7.1%) |
Mar 2024 | - | $431.24 M(-10.7%) |
Dec 2023 | $294.82 M(-1.8%) | $483.06 M(+4.3%) |
Sep 2023 | - | $463.26 M(+7.0%) |
Jun 2023 | - | $432.82 M(+8.3%) |
Mar 2023 | - | $399.70 M(-5.7%) |
Dec 2022 | $300.35 M(-2.6%) | $423.82 M(-7.6%) |
Sep 2022 | - | $458.54 M(-7.9%) |
Jun 2022 | - | $497.64 M(-4.1%) |
Mar 2022 | - | $518.90 M(-13.1%) |
Dec 2021 | $308.31 M(+0.4%) | $596.83 M(-8.3%) |
Sep 2021 | - | $650.54 M(+35.4%) |
Jun 2021 | - | $480.50 M(-4.5%) |
Mar 2021 | - | $502.89 M(-13.2%) |
Dec 2020 | $307.05 M(-7.0%) | $579.47 M(-1.0%) |
Sep 2020 | - | $585.28 M(+52.5%) |
Jun 2020 | - | $383.88 M(-5.9%) |
Mar 2020 | - | $407.95 M(-21.6%) |
Dec 2019 | $330.13 M(+38.2%) | $520.07 M(-9.8%) |
Sep 2019 | - | $576.66 M(-9.2%) |
Jun 2019 | - | $634.88 M(+31.4%) |
Mar 2019 | - | $483.05 M(-12.3%) |
Dec 2018 | $238.85 M(+1.6%) | $551.10 M(-8.3%) |
Sep 2018 | - | $601.03 M(+4.3%) |
Jun 2018 | - | $576.23 M(-2.7%) |
Mar 2018 | - | $592.03 M(+51.0%) |
Dec 2017 | $235.06 M(-66.3%) | $391.96 M(-9.1%) |
Sep 2017 | - | $431.01 M(+78.9%) |
Jun 2017 | - | $240.99 M(-18.6%) |
Mar 2017 | - | $296.21 M(-12.9%) |
Dec 2016 | $696.78 M(+0.7%) | $340.06 M(+53.4%) |
Sep 2016 | - | $221.71 M(+1.9%) |
Jun 2016 | - | $217.67 M(+29.2%) |
Mar 2016 | - | $168.51 M(-22.2%) |
Dec 2015 | $691.78 M | $216.60 M(-9.8%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2015 | - | $240.05 M(-34.2%) |
Jun 2015 | - | $365.00 M(+141.3%) |
Mar 2015 | - | $151.25 M(-2.2%) |
Dec 2014 | $55.39 M(+41.0%) | $154.58 M(+77.2%) |
Sep 2014 | - | $87.24 M(+9.8%) |
Jun 2014 | - | $79.42 M(+8.1%) |
Mar 2014 | - | $73.45 M(-16.8%) |
Dec 2013 | $39.28 M(+618.1%) | $88.28 M(+37.3%) |
Sep 2013 | - | $64.31 M(-16.7%) |
Jun 2013 | - | $77.18 M(-12.1%) |
Mar 2013 | - | $87.81 M(-16.1%) |
Dec 2012 | $5.47 M(+73.8%) | $104.62 M(-7.0%) |
Sep 2012 | - | $112.48 M(+6.4%) |
Jun 2012 | - | $105.67 M(-8.3%) |
Mar 2012 | - | $115.29 M(+73.0%) |
Dec 2011 | $3.15 M(+9.6%) | $66.65 M(-12.8%) |
Sep 2011 | - | $76.39 M(-13.3%) |
Jun 2011 | - | $88.10 M(-11.9%) |
Mar 2011 | - | $100.05 M(-8.8%) |
Dec 2010 | $2.87 M(-41.2%) | $109.68 M(+81.4%) |
Sep 2010 | - | $60.48 M(-15.0%) |
Jun 2010 | - | $71.15 M(-15.2%) |
Mar 2010 | - | $83.94 M(+4.3%) |
Dec 2009 | $4.88 M(-5.8%) | $80.49 M(-14.0%) |
Sep 2009 | - | $93.58 M(-9.2%) |
Jun 2009 | - | $103.08 M(-7.2%) |
Mar 2009 | - | $111.03 M(-10.2%) |
Dec 2008 | $5.19 M(+27.8%) | $123.59 M(-10.6%) |
Sep 2008 | - | $138.25 M(-5.7%) |
Jun 2008 | - | $146.62 M(-5.8%) |
Mar 2008 | - | $155.63 M(-4.5%) |
Dec 2007 | $4.06 M(-12.3%) | $163.04 M(+35.1%) |
Sep 2007 | - | $120.65 M(-5.1%) |
Jun 2007 | - | $127.16 M(+86.7%) |
Mar 2007 | - | $68.09 M(+23.8%) |
Dec 2006 | $4.63 M(+21.4%) | $55.02 M(+121.3%) |
Dec 2005 | $3.81 M | $24.86 M |
FAQ
- What is Amicus Therapeutics annual total current assets?
- What is the all time high annual current assets for Amicus Therapeutics?
- What is Amicus Therapeutics annual current assets year-on-year change?
- What is Amicus Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly current assets year-on-year change?
What is Amicus Therapeutics annual total current assets?
The current annual current assets of FOLD is $483.06 M
What is the all time high annual current assets for Amicus Therapeutics?
Amicus Therapeutics all-time high annual total current assets is $596.83 M
What is Amicus Therapeutics annual current assets year-on-year change?
Over the past year, FOLD annual total current assets has changed by +$59.24 M (+13.98%)
What is Amicus Therapeutics quarterly total current assets?
The current quarterly current assets of FOLD is $498.47 M
What is the all time high quarterly current assets for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly total current assets is $650.54 M
What is Amicus Therapeutics quarterly current assets year-on-year change?
Over the past year, FOLD quarterly total current assets has changed by +$35.22 M (+7.60%)